EyePoint Pharmaceuticals

Press Release

<< Back
Apr 02, 2019

EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences

WATERTOWN, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that members of the management team are scheduled to present at the following investor conferences:

  • H.C. Wainwright Global Life Sciences Conference on Monday, April 8 at 2:50 PM BST
  • 18th Annual Needham Healthcare Conference on Tuesday, April 9 at 8:00 AM ET

A live audio webcast and subsequent archived replay of the Needham Healthcare Conference presentation may be accessed via the Investors section of the Company's website at www.eyepoint.com. The replay will be available for 90 days after the event.

About EyePoint Pharmaceuticals

EyePoint Pharmaceuticals, Inc. (formerly pSivida Corp.) (www.eyepointpharma.com), headquartered in Watertown, MA, is a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products in indications with high unmet medical need to help improve the lives of patients with serious eye disorders. The Company has two products, YUTIQ™ and DEXYCU™, that were approved by the U.S. Food and Drug Administration in 2018 and have been launched directly in the U.S. during the first quarter of 2019.

Contacts

Investors:

Argot Partners
Kimberly Minarovich
(646) 368-8014
kimberly@argotpartners.com

Joseph Rayne
(617) 340-6075
joseph@argotpartners.com

Media:

Thomas Gibson
(201) 476-0322
tom@tomgibsoncommunications.com

eyepoint logo.png

Source: EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals